Structure Therapeutics Inc. GPCR
19.01 USD -1.35 (-6.63%)
Nov 5, 2026, 1:30 PM EST
18.80 Day range 20.56
18.80 52-week range 94.90
- YTD
- -72.67%
- 1 year
- -40.98%
Analyst view
Price target (mean) 107.29 +464.4% upside
Now 19.01
- Target (low)
- 70.00
- Target (mean)
- 107.29
- Target (high)
- 145.00
Ratings (0m) 16 15 buy · 1 hold · 0 sell
- Strong buy4
- Buy11
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 16
- 1 month ago 16
- 2 months ago 16
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.241 | -0.57 – 2.02 | -0.37 | +34.9% | 50.00M | 0.0% | 10 |
| Next quarter | -0.49 | -0.59 – -0.28 | 0.20 | -345.0% | 0 | 0.0% | 10 |
| Current year | -1.62 | -2.04 – 0.94 | -0.80 | -102.0% | 41.67M | 0.0% | 11 |
| Next year | -2.19 | -2.53 – -1.57 | -1.62 | -35.2% | 45.45K | -99.9% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 9, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Aug 7, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 7, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jun 11, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 27, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Mar 16, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 2, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 27, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jan 22, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jan 20, 2026 | Guggenheim | Maintained | Buy | Buy |
| Dec 19, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 12, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Dec 12, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Dec 11, 2025 | Jefferies | Maintained | Buy | Buy |
| Dec 9, 2025 | Citigroup | Maintained | Buy | Buy |
| Dec 9, 2025 | Stifel | Maintained | Buy | Buy |
| Dec 9, 2025 | Clear Street | Maintained | Buy | Buy |
| Aug 7, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 7, 2025 | Guggenheim | Maintained | Buy | Buy |
| Aug 7, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jun 23, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jun 23, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| May 12, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 2, 2025 | Citigroup | Initiated | — | Buy |
| Apr 22, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 28, 2025 | Citizens Capital Markets | Maintained | Market Outperform | Market Outperform |
| Feb 28, 2025 | William Blair | Initiated | — | Outperform |
| Jan 8, 2025 | Stifel | Initiated | — | Buy |
| Dec 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |